Groundbreaking device represents the best cure for type 2 diabetes
On May 7th, 2020 Dr. Kent Sasse announced the issuance of a non-provisional patent for his new sleeve tube device, a major breakthrough in the field of metabolic surgery. Millions with type 2 diabetes will benefit from Dr. Sasse’s revolutionary device – the best cure for diabetes.
The new device, Non-Provisional Patent Serial No. 15/838,057, H & H Reference No. (88537.0006), is designed to improve the sleeve gastrectomy procedure, a metabolic surgery that reduces the risk of life-threatening weight-related health conditions, including type 2 diabetes.
Unlike previous devices, the sleeve tube takes its shape from the natural contours of the body and curvature of the stomach, enabling the surgeon to perform each procedure in a manner that conforms to the human body and produces a more natural result.
“The sleeve tube is the culmination of years of work to make sleeve gastrectomy safer, simpler and more effective,” says inventor Dr. Sasse. Dr. Sasse is the medical director of the Renown Regional Medical Center which is a nationally accredited center for metabolic and bariatric surgery. The basis of this patented invention contributed permitted Dr. Sasse to personally reduce his sleeve leak rate to 0.0% in over 2,500 consecutive sleeve gastrectomy procedures.
“Through years of study of sleeve gastrectomy, we determined where the increased pressure zones arise, and how to lower complications of leak and stenosis with this new device,” says Dr. Sasse. With continuing innovations like the Sleeve Tube, Dr. Sasse says, “Metabolic surgery today is a 45-minute procedure with four Band-aids that is safer than an appendectomy. More importantly, it is the safest and most effective treatment of type 2 diabetes today.”
